Literature DB >> 33728148

Prolonged Altered Mental Status in a Diabetic Hemodialysis Patient.

Mojgan Jalalzadeh1, Ashok Chaudhari1, Donald Baumstein1.   

Abstract

Osmotic demyelination syndrome (ODS) is a demyelinating disorder of the central nervous system. It usually occurs with rapid correction of severe chronic hyponatremia. ODS is rarely seen as a complication of hyperglycemia. Herein, we report a rare presentation of ODS secondary to hyperosmolar hyperglycemic state. A 28-year-old female with type 1 diabetes, hypertension, seizure disorder, and end-stage renal disease on hemodialysis was brought from a shelter with two days of unresponsiveness and developed ODS after hyperosmolar hyperglycemic state in long-standing uncontrolled diabetes with normal serum electrolyte levels.
Copyright © 2021, Jalalzadeh et al.

Entities:  

Keywords:  end-stage renal disease (esrd); hyperosmolar hyperglycemic state; osmotic demyelination syndrome; type 1 diabetes mellitus

Year:  2021        PMID: 33728148      PMCID: PMC7936650          DOI: 10.7759/cureus.13132

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  15 in total

Review 1.  A review of the causes of central pontine myelinosis: yet another apoptotic illness?

Authors:  H Ashrafian; P Davey
Journal:  Eur J Neurol       Date:  2001-03       Impact factor: 6.089

2.  Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients.

Authors:  R D ADAMS; M VICTOR; E L MANCALL
Journal:  AMA Arch Neurol Psychiatry       Date:  1959-02

3.  Treatment of central pontine myelinolysis with thyrotropin-releasing hormone.

Authors:  Emile F Zein; Souheil E Karaa; Florence Rollot; Philippe Blanche; Raymond E Chemaly
Journal:  Presse Med       Date:  2006-04       Impact factor: 1.228

4.  Treatment of central pontine myelinolysis with plasmapheresis and immunoglobulins in liver transplant patient.

Authors:  Fuat H Saner; Susanne Koeppen; Marco Meyer; Matthias Kohnle; Stefan Herget-Rosenthal; Georgios C Sotiropoulos; Andreas Paul; Arnold Radtke; Massimo Malagó; Christoph E Broelsch
Journal:  Transpl Int       Date:  2007-12-05       Impact factor: 3.782

5.  Central pontine myelinolysis.

Authors:  J M S Pearce
Journal:  Eur Neurol       Date:  2008-11-25       Impact factor: 1.710

6.  Central pontine myelinolysis in a patient with hyperosmolar hyperglycemia and consistently normal serum sodium.

Authors:  Joseph D Burns; Steven C Kosa; Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2009-06-30       Impact factor: 3.210

7.  Peduncular hallucinosis secondary to central pontine myelinolysis.

Authors:  Mark Walterfang; Anita Goh; Ramon Mocellin; Andrew Evans; Dennis Velakoulis
Journal:  Psychiatry Clin Neurosci       Date:  2012-12       Impact factor: 5.188

8.  Central pontine lesions observed with MRI in four diabetic patients.

Authors:  Hiroo Ichikawa; Hidetomo Murakami; Hirotaka Katoh; Soutaro Hieda; Mitsuru Kawamura
Journal:  Intern Med       Date:  2008-08-01       Impact factor: 1.271

9.  Central pontine myelinolysis complicating treatment of the hyperglycaemic hyperosmolar state.

Authors:  Grainne O'Malley; Carla Moran; Mohd Shazlie Draman; Tom King; Diarmuid Smith; Chris J Thompson; Amar Agha
Journal:  Ann Clin Biochem       Date:  2008-07       Impact factor: 2.057

Review 10.  Hyponatremia and the Brain.

Authors:  Fabrice Gankam Kengne; Guy Decaux
Journal:  Kidney Int Rep       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.